Bellicum Pharmaceuticals, Inc. (BLCM)

OTCMKTS: BLCM · Delayed Price · USD
+0.036 (18.95%)
Nov 27, 2023, 3:25 PM EST - Market closed

Total Valuation

BLCM has a market cap or net worth of $2.43 million. The enterprise value is -$3.48 million.

Market Cap 2.43M
Enterprise Value -3.48M

Important Dates

The last earnings date was Tuesday, August 29, 2023, after market close.

Earnings Date Aug 29, 2023
Ex-Dividend Date n/a

Share Statistics

BLCM has 9.72 million shares outstanding. The number of shares has increased by 0.24% in one year.

Shares Outstanding 9.72M
Shares Change (YoY) +0.24%
Shares Change (QoQ) +0.23%
Owned by Insiders (%) 1.23%
Owned by Institutions (%) 25.05%
Float 6.28M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 1.61
Forward PS n/a
PB Ratio n/a
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 3.04

Current Ratio 3.04
Quick Ratio 2.63
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage 45.10

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -318.07%
Return on Capital (ROIC) n/a
Revenue Per Employee $116,000
Profits Per Employee -$1.68M
Employee Count 13
Asset Turnover 0.17
Inventory Turnover n/a


Income Tax -295,998
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -81.73% in the last 52 weeks. The beta is 1.36, so BLCM's price volatility has been higher than the market average.

Beta (1Y) 1.36
52-Week Price Change -81.73%
50-Day Moving Average 0.23
200-Day Moving Average 0.44
Relative Strength Index (RSI) 56.36
Average Volume (30 Days) 17,065

Short Selling Information

The latest short interest is 1.44 million, so 14.81% of the outstanding shares have been sold short.

Short Interest 1.44M
Short Previous Month 527,201
Short % of Shares Out 14.81%
Short % of Float 22.92%
Short Ratio (days to cover) 0.17

Income Statement

In the last 12 months, BLCM had revenue of $1.51 million and -$21.80 million in losses. Loss per share was -$1.58.

Revenue 1.51M
Gross Profit 1.51M
Operating Income -23.05M
Pretax Income -22.38M
Net Income -21.80M
EBITDA -25.33M
EBIT -25.34M
Loss Per Share -$1.58
Full Income Statement

Balance Sheet

The company has $5.91 million in cash and no debt, giving a net cash position of $5.91 million or $0.61 per share.

Cash & Cash Equivalents 5.91M
Total Debt n/a
Net Cash 5.91M
Net Cash Per Share $0.61
Equity / Book Value -27.01M
Book Value Per Share -2.78
Working Capital 4.60M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$22.85 million and capital expenditures -$11,000, giving a free cash flow of -$22.86 million.

Operating Cash Flow -22.85M
Capital Expenditures -11,000
Free Cash Flow -22.86M
FCF Per Share -$0.74
Full Cash Flow Statement


Gross margin is 100.00%, with operating and profit margins of -1,528.71% and -1,445.42%.

Gross Margin 100.00%
Operating Margin -1,528.71%
Pretax Margin -1,483.82%
Profit Margin -1,445.42%
EBITDA Margin -1,679.97%
EBIT Margin -1,680.57%
FCF Margin -1,515.98%

Dividends & Yields

BLCM does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Earnings Yield -897.28%
FCF Yield -941.08%
Dividend Growth (YoY) n/a
Payout Ratio n/a
Buyback Yield -0.24%
Shareholder Yield -0.24%

Analyst Forecast

Price Target n/a
Price Target Difference n/a
Analyst Consensus n/a
Analyst Count n/a
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a

Stock Splits

The last stock split was on February 6, 2020. It was a reverse split with a ratio of 1:10.

Last Split Date Feb 6, 2020
Split Type Reverse
Split Ratio 1:10


BLCM has an Altman Z-Score of -131.99 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -131.99
Piotroski F-Score 1